Does antenatal magnesium sulphate given to women at risk of preterm birth between 30 and 34 weeks' gestation reduce the risk of death or cerebral palsy in their children? - a randomised controlled trial
Does antenatal magnesium sulphate given to women at risk of preterm birth between 30 and 34 weeks' gestation reduce the risk of death or cerebral palsy in their children? - a randomised controlled trial
妊娠 30 至 34 周之间有早产风险的妇女产前服用硫酸镁是否可以降低孩子死亡或脑瘫的风险？
批准号：
nhmrc : GNT1022968
负责人：
A/Pr Dominic Wilkinson
金额：
$197.88万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2012
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2012-01-01 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antenatal magnesium sulphate is recommended prior to preterm birth at less than 30 weeks’ gestation. Whether there are benefits at later gestations is uncertain. This study is assessing whether magnesium sulphate given to women at risk of very preterm birth between 30 to 34 weeks’ gestation increases the chance of their baby surviving without cerebral palsy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Does bovine lactoferrin (bLF) reduce mortality and morbidity in very low birthweight infants?
-
批准号：nhmrc : 1047100
-
项目类别：Project Grants
-
资助金额：$153.55万
-
财政年份：2013
-
负责人：A/Pr Dominic Wilkinson
-
依托单位：
Does antenatal magnesium sulphate given to women at risk of preterm birth between 30 and 34 weeks' gestation reduce the risk of death or cerebral palsy in their children? - a randomised controlled trial
-
批准号：nhmrc : 1022968
-
项目类别：Project Grants
-
资助金额：$139.13万
-
财政年份：2012
-
负责人：A/Pr Dominic Wilkinson
-
依托单位：
Perinatal neuroimaging, prognosis and neuroethics
-
批准号：nhmrc : 1016641
-
项目类别：Early Career Fellowships
-
资助金额：$15.2万
-
财政年份：2011
-
负责人：A/Pr Dominic Wilkinson
-
依托单位：
海外基金
